Increased epithelial gap density in the noninflamed duodenum of children with inflammatory bowel diseases

Journal of Pediatric Gastroenterology and Nutrition

Volumn 63, Issue 6, 2016, Pages 644-650

  Zaidi, Deenaz ^a   Bording Jorgensen, Michael ^a   Huynh, Hien Q ^a   Carroll, Matthew W ^a   Turcotte, Jean Francois ^a   Sergi, Consolato ^a   Liu, Julia ^b   Wine, Eytan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Confocal endomicroscopy; Crohn disease; Cytokines; Intestinal barrier; Ulcerative colitis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 2; INTERLEUKIN 8; RNA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3;

ADOLESCENT; ARTICLE; CELL DENSITY; CHILD; CLINICAL ARTICLE; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DUODENOSCOPY; DUODENUM BIOPSY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GAP JUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMALL INTESTINE EPITHELIUM; ULCERATIVE COLITIS; CASE CONTROL STUDY; COLON; CONFOCAL MICROSCOPY; DUODENUM; EPITHELIUM; EPITHELIUM CELL; ILEUM; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; DUODENUM; EPITHELIAL CELLS; EPITHELIUM; FEMALE; GAP JUNCTIONS; HUMANS; ILEUM; MALE; MICROSCOPY, CONFOCAL; SEVERITY OF ILLNESS INDEX;

EID: 84959276937     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001182     Document Type: Article

References (33)

1. Zhang Y-Z, Li Y-Y. Inflammatory bowel disease: pathogenesis. World J Gastroenterol 2014;20:91-9.
2. Abramson O, Durant M, Mow W, et al. Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. J Pediatr 2010;157:233-9.
3. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: A population-based study. Am J Gastroenterol 2006;101:1559-68.
4. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.
5. Benchimol EI, Manuel DG, Guttmann A, et al. Changing age demographics of inflammatory bowel disease in Ontario, Canada. Inflamm Bowel Dis 2014;20:1761-9.
6. McGuckin MA, Eri R, Simms LA, et al. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009;15:100-13.
7. Watson AJM, Chu S, Sieck L, et al. Epithelial barrier function in vivo is sustained despite gaps in epithelial layers. Gastroenterology 2005;129:902-12.
8. Liu JJ, Madsen KL, Boulanger P, et al. Mind the gaps: confocal endomicroscopy showed increased density of small bowel epithelial gaps in inflammatory bowel disease. J Clin Gastroenterol 2011;45:240-5.
9. Kiesslich R, Goetz M, Angus EM, et al. Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy. Gastroenterology 2007;133:1769-78.
10. Kiesslich R, Duckworth CA, Moussata D, et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 2012;61:1146-53.
11. Lim LG, Neumann J, Hansen T, et al. Confocal endomicroscopy identifies loss of local barrier function in the duodenum of patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2014;20:892-900.
12. Liu JJ,Wong K, Thiesen AL, et al. Increased epithelial gaps in the small intestines of patients with inflammatory bowel disease: density matters. Gastrointest Endosc 2011;73:1174-80.
13. Ruemmele FM. Pediatric inflammatory bowel diseases: coming of age. Curr Opin Gastroenterol 2010;26:332-6.
14. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification. Inflamm Bowel Dis 2011;17:1314-21.
15. Turner D, Griffiths AM, Walters TD, et al. Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis 2012;18:55-62.
16. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: A prospective multicenter study. Gastroenterology 2007;133:423-32.
17. Solem CA, Loftus EV, Tremaine WJ, et al. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:707-12.
18. Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol 2014;14:329-42.
19. Bertiaux-Vandaële N, Youmba SB, Belmonte L, et al. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Am J Gastroenterol 2011;106:2165-73.
20. Liu J, Yang S,Wang Z, et al. Ubiquitin ligase A20 regulates p53 protein in human colon epithelial cells. J Biomed Sci 2013;20:74.
21. Levine A,Wine E. Effects of enteral nutrition on Crohn's disease: clues to the impact of diet on disease pathogenesis. Inflamm Bowel Dis 2013;19:1322-9.
22. John LJ, Fromm M, Schulzke J-D. Epithelial barriers in intestinal inflammation. Antioxid Redox Signal 2011;15:1255-70.
23. Liu JJ, Davis EM, Wine E, et al. Epithelial cell extrusion leads to breaches in the intestinal epithelium. Inflamm Bowel Dis 2013;19:912-21.
24. Bruewer M, Luegering A, Kucharzik T, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003;171:6164-72.
25. Madsen KL, Malfair D, Gray D, et al. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis 1999;5:262-70.
26. Vereecke L, Beyaert R, Loo G van. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol 2009;30:383-91.
27. Wertz IE, Newton K, Seshasayee D, et al. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature 2015; 528:1-6.
28. Barron L, Dooms H, Hoyer KK, et al. Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells. J Immunol 2010;185:6426-30.
29. Sadlack B, Merz H, Schorle H, et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-61.
30. Grimm MC, Elsbury SK, Pavli P, et al. Interleukin 8: cells of origin in inflammatory bowel disease. Gut 1996;38:90-8.
31. Hoffmann E, Dittrich-Breiholz O, Holtmann H, et al. Multiple control of interleukin-8 gene expression. J Leukoc Biol 2002;72:847-55.
32. Alipour M, Zaidi D, Valcheva R, et al. Mucosal barrier depletion and loss of bacterial diversity are primary abnormalities in paediatric ulcerative colitis. J Crohns Colitis 2015;10:462-71.
33. Marchiando AM, Shen L, Graham WV, et al. The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. Gastroenterology 2011;140: 1208-18.